| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Clinical Investigations |
-Fetoprotein-Messenger RNA and ß Human Chorionic Gonadotropin-Messenger RNA1
Department of Urology [A. L. A. H., H. M., A. B., H. R.], Institute of Virology [M. L., M. R.], and Department of Medicine, Tumor Research [A. H.] University of Essen, D-45122 Essen, Germany
By establishing sensitive nested reverse transcription-PCRs for the
detection of mRNA of
-fetoprotein (AFP) and ß human chorionic
gonadotropin (ßhCG), we investigated the presence of circulating
tumor cells in the peripheral blood of 119 patients with germ-cell
tumor. A total of 336 blood samples obtained before and during
therapy were examined with regard to clinical applicability. The
overall ratio of positive PCR results was 26.5% and was independent of
the serum concentration of AFP and hCG/ßhCG. No correlation of the
positivity for AFP-mRNA to serum AFP level was found. In contrast,
positive results in ßhCG-PCR were twice as frequent in patients with
elevated serum hCG/ßhCG levels as in those with normal serum
hCG/ßhCG levels (P = 0.012). To
develop a valid correlation to tumor stage, tumor histology, and
serum level of tumor markers, a subgroup of 36 patients was evaluated
before definite therapy. The subgroup revealed an overall ratio of
33.3% positive PCR results. The serum level of both of the markers did
not correlate with the detection of corresponding mRNA in peripheral
blood samples. However, positive ßhCG-PCR results were found
exclusively in patients with elevated serum hCG/ßhCG (6 of 18
versus 0 of 18; P =
0.019). Patients with stage IIC/III germ-cell tumor demonstrated nearly
twice the frequency of positive PCR results as patients with stage I
tumor [7 (41.2%) of 17 versus 4 (23.5%) of 17] in
this subgroup. With regard to histology, positive PCR results were
found mostly in embryonal carcinoma.
This article has been cited by other articles:
![]() |
J.-M. Costa, A. Benachi, M. Olivi, Y. Dumez, M. Vidaud, and E. Gautier Fetal Expressed Gene Analysis in Maternal Blood: A New Tool for Noninvasive Study of the Fetus Clin. Chem., June 1, 2003; 49(6): 981 - 983. [Full Text] [PDF] |
||||
![]() |
B. Saller, G. Feldmann, K. Haupt, M. Broecker, O. E. Janssen, M. Roggendorf, K. Mann, and M. Lu RT-PCR-Based Detection of Circulating Calcitonin-Producing Cells in Patients with Advanced Medullary Thyroid Cancer J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 292 - 296. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |